BIO’s Senior Director for Industry Research, David Thomas, will discuss the results from three new reports published this year. The majority of the presentation will cover emerging therapeutic company investment and deal trends. In addition, conclusions from recent reports on the state of innovation in depression, pain, and addiction will be reviewed in the context of a larger industry shift away from highly prevalent chronic diseases.

Session ID: 43181